NO996438L - Ny kombinasjon av antiastmamedikamenter - Google Patents

Ny kombinasjon av antiastmamedikamenter

Info

Publication number
NO996438L
NO996438L NO996438A NO996438A NO996438L NO 996438 L NO996438 L NO 996438L NO 996438 A NO996438 A NO 996438A NO 996438 A NO996438 A NO 996438A NO 996438 L NO996438 L NO 996438L
Authority
NO
Norway
Prior art keywords
new combination
asthma drugs
kit
active ingredient
asthma
Prior art date
Application number
NO996438A
Other languages
English (en)
Other versions
NO996438D0 (no
Inventor
Bengt Axelsson
Leif Kollstroem
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO996438D0 publication Critical patent/NO996438D0/no
Publication of NO996438L publication Critical patent/NO996438L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Abstract

Preparat eller kit som har som en første aktiv bestanddel formoterol, eller et salt eller solvatderivat derav, og som har som en annen aktiv bestanddel rofleponid, eller en fett- syreester derav. Det er også beskrevet fremgangsmåter for behandling av respiratoriske forstyrrelser ved anvendelse av nevnte preparat eller kit.
NO996438A 1997-06-27 1999-12-23 Ny kombinasjon av antiastmamedikamenter NO996438L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27
PCT/SE1998/001089 WO1999000134A1 (en) 1997-06-27 1998-06-08 New combination of antiasthma medicaments

Publications (2)

Publication Number Publication Date
NO996438D0 NO996438D0 (no) 1999-12-23
NO996438L true NO996438L (no) 2000-02-28

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996438A NO996438L (no) 1997-06-27 1999-12-23 Ny kombinasjon av antiastmamedikamenter

Country Status (16)

Country Link
EP (1) EP1009408A1 (no)
JP (1) JP2002510310A (no)
KR (1) KR20010014162A (no)
AU (1) AU8135098A (no)
BR (1) BR9810452A (no)
CA (1) CA2295076A1 (no)
EE (1) EE9900594A (no)
HU (1) HUP0002533A3 (no)
ID (1) ID24063A (no)
IL (1) IL133597A0 (no)
IS (1) IS5303A (no)
NO (1) NO996438L (no)
PL (1) PL337722A1 (no)
SK (1) SK184799A3 (no)
TR (1) TR199903272T2 (no)
WO (1) WO1999000134A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
WO2004028545A1 (en) * 2002-09-25 2004-04-08 Astrazeneca Ab A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
AU673660C (en) * 1991-12-18 2002-07-25 Astrazeneca Ab New combination of formoterol and budesonide
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
AU8135098A (en) 1999-01-19
ID24063A (id) 2000-07-06
IS5303A (is) 1999-12-15
IL133597A0 (en) 2001-04-30
HUP0002533A3 (en) 2001-03-28
EP1009408A1 (en) 2000-06-21
PL337722A1 (en) 2000-08-28
HUP0002533A2 (hu) 2000-12-28
CA2295076A1 (en) 1999-01-07
KR20010014162A (ko) 2001-02-26
TR199903272T2 (xx) 2000-08-21
JP2002510310A (ja) 2002-04-02
BR9810452A (pt) 2000-09-05
SK184799A3 (en) 2000-06-12
EE9900594A (et) 2000-08-15
NO996438D0 (no) 1999-12-23
WO1999000134A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
NO950774L (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
NO982414L (no) Ny kombinasjon
NO20005431L (no) Gelerbare farmasoytiske preparater
HUP0303083A2 (hu) CETP-gátló és atorvasztatin terápiás kombinációját tartalmazó gyógyszerkészítmények és alkalmazásuk
NO951498L (no) Farmasöytisk preparat for behandling av osteoporose
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
HUP0104258A2 (hu) HMG-CoA reduktáz inhibítort tartalmazó stabil gyógyszerkészítmények
ES2185307T3 (es) Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
BR9611802A (pt) Composições farmacêuticas
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
BRPI0411255A (pt) composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto
BR0211673A (pt) Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
PA8559401A1 (es) Sales de acido succinico de 5,7,14-triazatetraciclo (10.3.1.0 2,11.0 4, 9)-hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
HUP0104410A2 (hu) Ateroszklerózis megelőzésére és/vagy kezelésére szolgáló gyógyszerkészítmények
DE59608698D1 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
BR0317567A (pt) Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação
CA2218766A1 (fr) Composes bicycliques-aromatiques
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
BG98827A (en) Pharmaceutical composition and method for its preparation
BR0110184A (pt) Derivado de piridina-1-óxido, e processo para a sua transformação em compostos farmaceuticamente eficazes
NO20043001L (no) Farmasoytisk formulering omfattende cyklosporin og anvendelse derav
EA199900226A1 (ru) Фармацевтические композиции для лечения вирусных заболеваний

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application